US Stock MarketDetailed Quotes

Takeda Pharmaceutical (TAK)

Watchlist
  • 16.640
  • +0.220+1.34%
Close May 13 16:00 ET
52.58BMarket Cap43.91P/E (TTM)

Takeda Pharmaceutical (TAK) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Mar 31, 2026
(Q4)Mar 31, 2026
(Q3)Dec 31, 2025
(Q2)Sep 30, 2025
(Q1)Jun 30, 2025
(FY)Mar 31, 2025
(Q4)Mar 31, 2025
(Q3)Dec 31, 2024
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
Total revenue
-1.66%4.51T
3.91%1.09T
4.16%1.19T
-5.38%1.11T
-8.39%1.11T
7.45%4.58T
0.24%1.05T
2.96%1.14T
12.75%1.18T
14.11%1.21T
Operating revenue
-1.66%4.51T
3.91%1.09T
4.16%1.19T
-5.38%1.11T
-8.39%1.11T
7.45%4.58T
0.24%1.05T
2.96%1.14T
12.75%1.18T
14.11%1.21T
Cost of revenue
-0.55%1.57T
6.18%405.7B
-3.77%401.15B
-3.61%380.06B
-0.59%384.68B
10.76%1.58T
-0.11%382.08B
9.85%416.87B
14.76%394.31B
20.50%386.95B
Gross profit
-2.24%2.93T
2.61%688.84B
8.70%790.55B
-6.27%732.74B
-12.06%722.01B
5.79%3T
0.44%671.32B
-0.61%727.25B
11.75%781.73B
11.33%821.04B
Operating expense
0.40%2.53T
16.54%702.46B
-5.84%621.73B
11.09%663.74B
-17.91%537.45B
1.80%2.52T
14.52%602.78B
-16.71%660.31B
-20.21%597.48B
15.08%654.71B
Selling and administrative expenses
-1.86%1.08T
-1.31%292B
4.51%282.78B
-5.49%253.55B
-5.24%255.89B
4.83%1.1T
3.73%295.87B
1.15%270.59B
6.06%268.28B
8.83%270.03B
Research and development costs
-7.44%675.92B
-9.58%195.32B
2.96%175.23B
-8.02%161.48B
-14.59%143.89B
0.04%730.23B
10.29%216.01B
-9.17%170.19B
-4.56%175.56B
3.52%168.46B
Depreciation amortization depletion
-1.51%633.54B
-23.75%154.84B
5.19%141.91B
44.06%205.16B
-19.16%131.64B
-1.36%643.23B
39.94%203.08B
-46.69%134.91B
-40.72%142.41B
25.81%162.83B
-Depreciation and amortization
-1.51%633.54B
-23.75%154.84B
5.19%141.91B
44.06%205.16B
-19.16%131.64B
-1.36%643.23B
39.94%203.08B
-46.69%134.91B
-40.72%142.41B
25.81%162.83B
Other operating expenses
255.46%131.69B
153.76%60.31B
-74.24%21.8B
288.16%43.55B
-88.70%6.03B
5.67%37.05B
-12.33%-112.17B
-0.22%84.61B
-84.35%11.22B
86.29%53.38B
Operating profit
-15.90%408.76B
-119.87%-13.62B
152.19%168.82B
-62.55%69B
10.96%184.57B
32.74%486.06B
-51.74%68.54B
209.60%66.94B
473.41%184.25B
-1.33%166.33B
Net non-operating interest income expense
-3.34%-146.4B
-295.53%-38.5B
7.33%-35.76B
39.78%-38.74B
-15.12%-33.4B
-0.86%-141.67B
29.98%-9.73B
13.83%-38.58B
-32.21%-64.34B
12.40%-29.01B
Non-operating interest income
975.35%211.18B
163.08%5.15B
1,357.46%87.87B
978.62%44.4B
140.43%73.76B
73.90%19.64B
76.54%-8.17B
-132.07%-6.99B
-56.02%4.12B
15.96%30.68B
Non-operating interest expense
160.41%357.57B
294.60%43.65B
291.27%123.63B
21.45%83.14B
79.52%107.16B
14.87%137.31B
57.78%-22.43B
-52.54%31.6B
17.98%68.45B
0.19%59.69B
Total other finance cost
----
----
----
----
----
-25.53%24B
----
----
----
----
Other net income (expense)
98.71%-2.18B
99.78%-361M
140.93%799M
-288.60%-2.08B
24.72%-536M
2.08%-169.31B
5.43%-166.11B
-101.17%-1.95B
-126.42%-535M
-70.33%-712M
Gain on sale of security
----
----
----
----
----
183.25%7.6B
----
----
----
----
Earnings from equity interest
45.38%-2.18B
54.13%-361M
140.93%799M
-288.60%-2.08B
24.72%-536M
-161.58%-3.99B
-121.03%-787M
-273.67%-1.95B
-126.42%-535M
-70.33%-712M
Special income (charges)
----
----
----
----
----
-1.57%-172.92B
----
----
----
----
-Less:Restructuring and merger&acquisition
----
----
----
----
----
24.89%127.53B
----
----
----
----
-Less:Other special charges
----
----
----
----
----
-40.72%37.57B
----
----
----
----
-Write off
----
----
----
----
----
44.34%18.38B
----
----
----
----
-Gain on sale of business
----
----
----
----
----
30.23%10.2B
----
----
----
----
-Gain on sale of property,plant,equipment
----
----
----
----
----
152.08%363M
----
----
----
----
Income before tax
48.61%260.19B
51.09%-52.48B
406.93%133.86B
-76.40%28.17B
10.27%150.63B
231.66%175.08B
-125.79%-107.3B
-56.89%26.41B
224.37%119.37B
1.16%136.6B
Income tax
1.83%68.16B
-571.79%-28.22B
1,071.50%30.13B
46.35%39.9B
-36.20%26.35B
173.23%66.94B
90.57%-4.2B
105.78%2.57B
156.79%27.27B
-9.47%41.3B
Net income
77.57%192.03B
76.47%-24.26B
335.21%103.73B
-112.73%-11.73B
30.41%124.28B
-25.00%108.14B
-3,343.49%-103.1B
-77.46%23.84B
292.01%92.11B
6.59%95.3B
Net income continuous Operations
77.57%192.03B
76.47%-24.26B
335.21%103.73B
-112.73%-11.73B
30.41%124.28B
-25.00%108.14B
-3,343.49%-103.1B
-77.46%23.84B
292.00%92.11B
6.59%95.3B
Minority interest income
22.79%264M
8.77%62M
104.35%94M
18.03%72M
-29.41%36M
65.38%215M
137.50%57M
31.43%46M
3.39%61M
363.64%51M
Net income attributable to the parent company
77.68%191.76B
76.42%-24.32B
335.66%103.64B
-112.82%-11.8B
30.44%124.24B
-25.08%107.93B
-3,317.99%-103.16B
-77.50%23.79B
291.64%92.05B
6.55%95.25B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
77.68%191.76B
76.42%-24.32B
335.66%103.64B
-112.82%-11.8B
30.44%124.24B
-25.08%107.93B
-3,317.99%-103.16B
-77.50%23.79B
291.64%92.05B
6.55%95.25B
Basic earnings per share
78.10%60.875
76.19%-7.78
342.40%32.87
-113.47%-3.915
30.79%39.7
-25.77%34.18
-3,151.24%-32.675
-78.01%7.43
289.50%29.07
5.56%30.355
Diluted earnings per share
77.96%59.82
76.19%-7.78
343.62%32.34
-113.70%-3.915
30.51%39.115
-26.25%33.615
-3,151.24%-32.675
-78.20%7.29
286.34%28.585
4.94%29.97
Dividend per share
-50.80%47.8738
0
0
2.80%47.8738
0
5.89%97.2997
14.71%50.7303
0
-2.29%46.5694
0
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Mar 31, 2026(Q4)Mar 31, 2026(Q3)Dec 31, 2025(Q2)Sep 30, 2025(Q1)Jun 30, 2025(FY)Mar 31, 2025(Q4)Mar 31, 2025(Q3)Dec 31, 2024(Q2)Sep 30, 2024(Q1)Jun 30, 2024
Total revenue -1.66%4.51T3.91%1.09T4.16%1.19T-5.38%1.11T-8.39%1.11T7.45%4.58T0.24%1.05T2.96%1.14T12.75%1.18T14.11%1.21T
Operating revenue -1.66%4.51T3.91%1.09T4.16%1.19T-5.38%1.11T-8.39%1.11T7.45%4.58T0.24%1.05T2.96%1.14T12.75%1.18T14.11%1.21T
Cost of revenue -0.55%1.57T6.18%405.7B-3.77%401.15B-3.61%380.06B-0.59%384.68B10.76%1.58T-0.11%382.08B9.85%416.87B14.76%394.31B20.50%386.95B
Gross profit -2.24%2.93T2.61%688.84B8.70%790.55B-6.27%732.74B-12.06%722.01B5.79%3T0.44%671.32B-0.61%727.25B11.75%781.73B11.33%821.04B
Operating expense 0.40%2.53T16.54%702.46B-5.84%621.73B11.09%663.74B-17.91%537.45B1.80%2.52T14.52%602.78B-16.71%660.31B-20.21%597.48B15.08%654.71B
Selling and administrative expenses -1.86%1.08T-1.31%292B4.51%282.78B-5.49%253.55B-5.24%255.89B4.83%1.1T3.73%295.87B1.15%270.59B6.06%268.28B8.83%270.03B
Research and development costs -7.44%675.92B-9.58%195.32B2.96%175.23B-8.02%161.48B-14.59%143.89B0.04%730.23B10.29%216.01B-9.17%170.19B-4.56%175.56B3.52%168.46B
Depreciation amortization depletion -1.51%633.54B-23.75%154.84B5.19%141.91B44.06%205.16B-19.16%131.64B-1.36%643.23B39.94%203.08B-46.69%134.91B-40.72%142.41B25.81%162.83B
-Depreciation and amortization -1.51%633.54B-23.75%154.84B5.19%141.91B44.06%205.16B-19.16%131.64B-1.36%643.23B39.94%203.08B-46.69%134.91B-40.72%142.41B25.81%162.83B
Other operating expenses 255.46%131.69B153.76%60.31B-74.24%21.8B288.16%43.55B-88.70%6.03B5.67%37.05B-12.33%-112.17B-0.22%84.61B-84.35%11.22B86.29%53.38B
Operating profit -15.90%408.76B-119.87%-13.62B152.19%168.82B-62.55%69B10.96%184.57B32.74%486.06B-51.74%68.54B209.60%66.94B473.41%184.25B-1.33%166.33B
Net non-operating interest income expense -3.34%-146.4B-295.53%-38.5B7.33%-35.76B39.78%-38.74B-15.12%-33.4B-0.86%-141.67B29.98%-9.73B13.83%-38.58B-32.21%-64.34B12.40%-29.01B
Non-operating interest income 975.35%211.18B163.08%5.15B1,357.46%87.87B978.62%44.4B140.43%73.76B73.90%19.64B76.54%-8.17B-132.07%-6.99B-56.02%4.12B15.96%30.68B
Non-operating interest expense 160.41%357.57B294.60%43.65B291.27%123.63B21.45%83.14B79.52%107.16B14.87%137.31B57.78%-22.43B-52.54%31.6B17.98%68.45B0.19%59.69B
Total other finance cost ---------------------25.53%24B----------------
Other net income (expense) 98.71%-2.18B99.78%-361M140.93%799M-288.60%-2.08B24.72%-536M2.08%-169.31B5.43%-166.11B-101.17%-1.95B-126.42%-535M-70.33%-712M
Gain on sale of security --------------------183.25%7.6B----------------
Earnings from equity interest 45.38%-2.18B54.13%-361M140.93%799M-288.60%-2.08B24.72%-536M-161.58%-3.99B-121.03%-787M-273.67%-1.95B-126.42%-535M-70.33%-712M
Special income (charges) ---------------------1.57%-172.92B----------------
-Less:Restructuring and merger&acquisition --------------------24.89%127.53B----------------
-Less:Other special charges ---------------------40.72%37.57B----------------
-Write off --------------------44.34%18.38B----------------
-Gain on sale of business --------------------30.23%10.2B----------------
-Gain on sale of property,plant,equipment --------------------152.08%363M----------------
Income before tax 48.61%260.19B51.09%-52.48B406.93%133.86B-76.40%28.17B10.27%150.63B231.66%175.08B-125.79%-107.3B-56.89%26.41B224.37%119.37B1.16%136.6B
Income tax 1.83%68.16B-571.79%-28.22B1,071.50%30.13B46.35%39.9B-36.20%26.35B173.23%66.94B90.57%-4.2B105.78%2.57B156.79%27.27B-9.47%41.3B
Net income 77.57%192.03B76.47%-24.26B335.21%103.73B-112.73%-11.73B30.41%124.28B-25.00%108.14B-3,343.49%-103.1B-77.46%23.84B292.01%92.11B6.59%95.3B
Net income continuous Operations 77.57%192.03B76.47%-24.26B335.21%103.73B-112.73%-11.73B30.41%124.28B-25.00%108.14B-3,343.49%-103.1B-77.46%23.84B292.00%92.11B6.59%95.3B
Minority interest income 22.79%264M8.77%62M104.35%94M18.03%72M-29.41%36M65.38%215M137.50%57M31.43%46M3.39%61M363.64%51M
Net income attributable to the parent company 77.68%191.76B76.42%-24.32B335.66%103.64B-112.82%-11.8B30.44%124.24B-25.08%107.93B-3,317.99%-103.16B-77.50%23.79B291.64%92.05B6.55%95.25B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 77.68%191.76B76.42%-24.32B335.66%103.64B-112.82%-11.8B30.44%124.24B-25.08%107.93B-3,317.99%-103.16B-77.50%23.79B291.64%92.05B6.55%95.25B
Basic earnings per share 78.10%60.87576.19%-7.78342.40%32.87-113.47%-3.91530.79%39.7-25.77%34.18-3,151.24%-32.675-78.01%7.43289.50%29.075.56%30.355
Diluted earnings per share 77.96%59.8276.19%-7.78343.62%32.34-113.70%-3.91530.51%39.115-26.25%33.615-3,151.24%-32.675-78.20%7.29286.34%28.5854.94%29.97
Dividend per share -50.80%47.8738002.80%47.873805.89%97.299714.71%50.73030-2.29%46.56940
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More